Homepage
Continuous flow chemistry

At Fluidichem, we are revolutionising drug development with cutting-edge technology. Our innovative approach combines artificial intelligence (AI) with continuous flow chemistry to transform the synthesis of molecule libraries. This groundbreaking solution ensures rapid and efficient drug development across all phases beyond discovery.
At the heart of our work lies our high-throughput automated synthesis robot, based on continuous flow chemistry and leveraging AI support to guarantee speed, efficiency and adaptability.
Services customized for your industry
Our team
At Fluidichem, our team is the driving force behind our innovation and success. With diverse expertise in chemistry, automation, IA and industrial applications, each member brings a unique perspective to solving today’s challenges in molecule libraries synthesis. We are united by a shared commitment to reactivity, flexibility and excellence for our clients worldwide.

Eric WIMMER
CEO

Nour EL SABBAGH
Research Engineer

Vincent DELATTRE
Research Engineer